Cipla could deliver healthy growth of 5% in the Indian business in the second quarter, but the US business is likely to witness pressure on account of lower Albuterol Sulphate sales. Revenue for the quarter is likely to grow at 13% year-on-year (YoY), according to an average estimate of three brokerages, and net profit for the same period is expected to rise around 19% YoY.
Melania Trump rings New York Stock Exchange opening bell to launch new women’s initiative Imperia
On Wednesday, Melania Trump celebrated the launch of her initiative, Imperia, at the New York Stock Exchange, championing women’s leadership and economic empowerment. She emphasized